Ana Álvarez‐Uría

Dalbavancin in the treatment of different gram-positive infections: a real-life experience

Emilio Bouza, Maricela Valerio, Àlex Soriano et al. · International Journal of Antimicrobial Agents · 2017 · 154 citations

Anti-infective Agents, Health Sciences, Antibiotics +10

Risk factors for late recurrent candidaemia. A retrospective matched case–control study

Patricia Muñóz, Antonio Vena, Maricela Valerio et al. · Clinical Microbiology and Infection · 2015 · 49 citations

Diagnostic Mycology, Case–control Study, Late Recurrent Candidaemia +6

Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study)

Adaia Albasanz‐Puig, Carlota Gudiol, Pedro Puerta‐Alcalde et al. · Antimicrobial Agents and Chemotherapy · 2021 · 48 citations · Full text

Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?

Antonio Vena, Patricia Muñóz, Miriam Mateos et al. · Infectious Diseases and Therapy · 2020 · 39 citations · Full text

The misleading effect of serum galactomannan testing in high-risk haematology patients receiving prophylaxis with micafungin

Antonio Vena, Emilio Bouza, Ana Álvarez‐Uría et al. · Clinical Microbiology and Infection · 2017 · 37 citations

Serum Galactomannan, Cardiovascular Disease, Patient Safety +8